Rationale and Design of the COPERNIC Trial: A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients.

Auteurs

Assaf I, Bregni G, Anthoine G, Aparicio T, Artru P, Abdelghani MB, Buyse M, Chibaudel B, Coart E, Diaz M, Evrard C, Geboes K, Ghiringhelli F, Puleo F, Raimbourg J, Vandamme T, Van den Eynde M, Hendlisz A, Sclafani F

  • Date de publication

    September 2024
  • Type

    Article
  • Review

    Clin Colorectal Cancer
  • Researcher's name

    SCLAFANI FRANCESCO
  • Hôpital

    Institut Jules Bordet
  • Service

    Oncologie digestive
  • PMID

    39341700
  • DOI

    10.1016/j.clcc.2024.08.004